Lessons from the Pandemic: COVID-19 and Health-Pharma Investigations

During the COVID-19 pandemic, journalists worldwide were suddenly thrown into the public health beat, trying to make sense of competing claims, and a science that seemed to change by the day. A session at the GIJC21 walked reporters through the COVID-19 pandemic, offering tips on covering the drug development and approval processes, evaluating scientific studies, unearthing conflicts of interest, and exposing fraud and malpractice.

Data Journalists Offer Tools for the Future

Data journalism has evolved from simple spreadsheet analysis of local government data to the spectacular tracking of the hidden wealth of oligarchs, autocrats, and corporate leaders from gigantic datasets. In a session at GIJC21, leading data journalists looked at this transition but also, at what is next.